Avanza Fonder Ab Health Catalyst, Inc. Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 26,050 shares of HCAT stock, worth $140,409. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,050Holding current value
$140,409% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HCAT
# of Institutions
176Shares Held
50.5MCall Options Held
2.97MPut Options Held
16.1K-
Black Rock Inc. New York, NY5.43MShares$29.3 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN5.24MShares$28.2 Million3.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.39MShares$23.7 Million0.0% of portfolio
-
Impax Asset Management Group PLC2.75MShares$14.8 Million0.1% of portfolio
-
Daventry Group, LP New York, NY2.51MShares$13.5 Million6.78% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $295M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...